Federica Cavallo

About Federica Cavallo

Federica Cavallo, With an exceptional h-index of 60 and a recent h-index of 35 (since 2020), a distinguished researcher at Università degli Studi di Torino, specializes in the field of Immunology, tumor immunology, immunotherapy.

His recent articles reflect a diverse array of research interests and contributions to the field:

Non-Hodgkin lymphoma treated with anti-CD20 antibody-based immunochemotherapy

Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease

The definitive version is available at

p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response

Adamantinoma-like Ewing sarcoma of the salivary glands: a case report and systematic literature review

A chimeric Human/Dog CSPG4 DNA vaccine reveals potential therapeutic effects for the treatment of melanoma

Maternal immunization against ALK: A new weapon against Neuroblastoma

829 A potent STING agonist in combination with a novel anti-PD-L1/PD-L2 antibody leads to significant tumor responses in checkpoint-refractory cancers

Federica Cavallo Information

University

Position

Full professor of Immunology Italy

Citations(all)

14511

Citations(since 2020)

4367

Cited By

10851

hIndex(all)

60

hIndex(since 2020)

35

i10Index(all)

178

i10Index(since 2020)

103

Email

University Profile Page

Google Scholar

Federica Cavallo Skills & Research Interests

Immunology

tumor immunology

immunotherapy

Top articles of Federica Cavallo

Non-Hodgkin lymphoma treated with anti-CD20 antibody-based immunochemotherapy

2024/1/1

Simone Ragaini
Simone Ragaini

H-Index: 1

Federica Cavallo
Federica Cavallo

H-Index: 29

Assessment of BoHV-4-based vector vaccine intranasally administered in a hamster challenge model of lung disease

Frontiers in Immunology

2023/7/6

Valentina Franceschi
Valentina Franceschi

H-Index: 14

Federica Cavallo
Federica Cavallo

H-Index: 29

p140Cap inhibits β-Catenin in the breast cancer stem cell compartment instructing a protective anti-tumor immune response

Nature Communications

2023/5/11

Adamantinoma-like Ewing sarcoma of the salivary glands: a case report and systematic literature review

Therapeutic Advances in Medical Oncology

2023/4

Federica Cavallo
Federica Cavallo

H-Index: 29

A chimeric Human/Dog CSPG4 DNA vaccine reveals potential therapeutic effects for the treatment of melanoma

CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY

2023/3/29

Federica Cavallo
Federica Cavallo

H-Index: 29

Maternal immunization against ALK: A new weapon against Neuroblastoma

CANCERTO-NANOSCIENCE IN CANCER IMMUNOTHERAPY

2023/3/29

829 A potent STING agonist in combination with a novel anti-PD-L1/PD-L2 antibody leads to significant tumor responses in checkpoint-refractory cancers

2023/11/1

Cystine/glutamate antiporter xCT deficiency reduces metastasis without impairing immune system function in breast cancer mouse models

Journal of Experimental & Clinical Cancer Research

2023/9/29

Luca Ponzone
Luca Ponzone

H-Index: 1

Federica Cavallo
Federica Cavallo

H-Index: 29

A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma

Blood Advances

2023/8/8

A chimeric human/dog-DNA vaccine against CSPG4 induces immunity with therapeutic potential in comparative preclinical models of osteosarcoma

Molecular Therapy

2023/8/2

Federica Cavallo
Federica Cavallo

H-Index: 29

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial

Blood advances

2023/7/25

Canine melanoma immunology and immunotherapy: relevance of translational research

Frontiers in Veterinary Science

2022/2/11

Federica Cavallo
Federica Cavallo

H-Index: 29

Cost efficiency and effectiveness of biosimilar filgrastim in autologous transplant

Bone Marrow Transplantation

2022/2

Federica Cavallo
Federica Cavallo

H-Index: 29

Mario Boccadoro
Mario Boccadoro

H-Index: 58

Role of ADCC, CDC, and CDCC in Vaccine-Mediated Protection against Her2 Mammary Carcinogenesis

Biomedicines

2022/1/21

Federica Cavallo
Federica Cavallo

H-Index: 29

Role and involvement of Tenm4 and miR-708 in breast cancer development and therapy

2022/1/5

Federica Cavallo
Federica Cavallo

H-Index: 29

The 21st International Conference on Progress in Vaccination against Cancer (PIVAC-22), September 26-28, 2022, Turin, Italy

FRONTIERS IN BIOSCIENCE

2022

Federica Cavallo
Federica Cavallo

H-Index: 29

Antigen mimicry as an effective strategy to induce CSPG4-targeted immunity in dogs with oral melanoma: a veterinary trial

Journal for Immunotherapy of Cancer

2022

Federica Cavallo
Federica Cavallo

H-Index: 29

Toll-like receptor 2 promotes breast cancer progression and resistance to chemotherapy

Oncoimmunology

2022/12/31

RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment

Cancers

2022/12/20

Enza Di Gregorio
Enza Di Gregorio

H-Index: 15

Federica Cavallo
Federica Cavallo

H-Index: 29

See List of Professors in Federica Cavallo University(Università degli Studi di Torino)

Co-Authors

academic-engine